epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

J Clin Sleep Med

1h

Can a smartwatch flag hidden sleep apnea?

Consumer wearable identified moderate-to-severe OSA in a validation study, with especially strong performance in high-risk patients. . .

OTC update

1d

New sunscreen ingredient reaches US shelves after decades abroad

Bemotrizinol offers UVA and UVB protection with low systemic absorption and less concern about white residue. . .

Ann Intern Med

1d

Study eases concerns over benzodiazepine exposure in early pregnancy

Data from 4.2 million pregnancies offer reassurance about first-trimester benzodiazepine exposure and major birth-defect risk. . .

Neurology

1d

Who gets Alzheimer’s drugs? Racial and socioeconomic gaps persist

Black, Hispanic, and socioeconomically vulnerable adults had lower treatment use, while race and ethnicity were not linked to initial adherence. . .

EClinicalMedicine

1d

Drug-coated balloons match stents in coronary disease

Meta-analysis suggests many patients with de novo coronary disease may avoid permanent stent implantation without sacrificing major cardiovascular outcomes. . .

N Engl J Med

1d

Strongest evidence yet backs CGMs without insulin

Largest trial to date found more time in range, greater A1c reductions, and nearly twice the likelihood of reaching glycemic targets. . .

JAMA Netw Open

1d

Ultra-processed foods tied to silent brain injury in midlife

MRI study links higher intake to covert vascular brain lesions and greater adiposity, even before cognitive changes emerge. . .

FDA

1d

FDA expands Anktiva approval in BCG-unresponsive NMIBC

Broader eligibility brings a bladder-sparing option to patients previously without an indicated therapy. . .

N Engl J Med

1d

ACG 2026: Oral IL-23 blocker shows promise for ulcerative colitis

Once-daily oral icotrokinra improved remission, symptoms, and endoscopic outcomes in a phase 2b trial. . .

Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information